Lv1
38 积分 2024-05-28 加入
Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies
6小时前
待确认
Expert Consensus on Cytomegalovirus Management in Recipients of CAR‐T Cell and Bispecific Antibody Therapies
6小时前
已完结
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies
22天前
已完结
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee
28天前
已完结
Novel strategies to manage CAR-T cell toxicity
28天前
已完结
Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
28天前
已完结
Current understanding and management of CAR T cell-associated toxicities
28天前
已完结
Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphoma
28天前
已完结
CAR T-cell therapy combined with autologous hematopoietic cell transplantation in patients with refractory/relapsed Burkitt Lymphoma
1个月前
已完结
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma
1个月前
已完结
皖公网安备34019202002308
